Human EP3I prostanoid receptor induces VEGF and VEGF receptor-1 mRNA expression

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1173-1178

  Taniguchi, Tomoko ^a   Fujino, Hiromichi ^a   Israel, Davelene D ^b   Regan, John W ^b   Murayama, Toshihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

EP3I receptor; PGE2; VEGF; VEGFR 1

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; PROSTANOID RECEPTOR EP3I; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; STIMULATION; UPREGULATION;

ADIPOGENESIS; BUTADIENES; DINOPROSTONE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

MUS;

EID: 56349086501     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.140     Document Type: Article

References (24)

1. Regan J.W. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74 (2003) 143-153
2. Kotani M., Tanaka I., Ogawa Y., Usui T., Tamura N., Mori K., Narumiya S., Yoshimi T., and Nakao K. Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3). Genomics 40 (1997) 425-434
3. Hatae N., Sugimoto Y., and Ichikawa A. Prostaglandin receptors: advances in the study of EP3 receptor signaling. J. Biochem. 131 (2002) 781-784
4. Regan J.W., Bailey T.J., Donello J.E., Pierce K.L., Pepperl D.J., Zhang D., Kedzie K.M., Fairbairn C.E., Bogardus A.M., Woodward D.F., and Gil D.W. Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini. Br. J. Pharmacol. 112 (1994) 377-385
5. 2. Eur. J. Biochem. 228 (1995) 23-30
6. 2 receptor transduce both intracellular calcium and cAMP signals. Biochemistry 33 (1994) 14496-14502
7. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., and Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365 (1993) 166-170
8. Burkey T.H., and Regan J.W. Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor. Biochem. Biophys. Res. Commun. 211 (1995) 152-158
9. Kotani M., Tanaka I., Ogawa Y., Usui T., Mori K., Ichikawa A., Narumiya S., Yoshimi T., and Nakao K. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol. Pharmacol. 48 (1995) 869-879
10. Kotani M., Tanaka I., Ogawa Y., Suganami T., Matsumoto T., Muro S., Yamamoto Y., Sugawara A., Yoshimasa Y., Sagawa N., Narumiya S., and Nakao K. Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. J. Clin. Endocrinol. Metab. 85 (2000) 4315-4322
11. Δ716 knockout mice. Nat. Med. 7 (2001) 1048-1051
12. Watanabe K., Kawamori T., Nakatsugi S., Ohta T., Ohuchida S., Yamamoto H., Maruyama T., Kondo K., Ushikubi F., Narumiya S., Sugimura T., and Wakabayashi K. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res. 59 (1999) 5093-5096
13. 2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J. Exp. Med. 197 (2003) 221-232
14. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25 (2004) 581-611
15. Kamoshita E., Ikeda Y., Fujita M., Amano H., Oikawa A., Suzuki T., Ogawa Y., Yamashina S., Azuma S., Narumiya S., Unno N., and Majima M. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am. J. Pathol. 169 (2006) 1458-1472
16. 2. J. Biol. Chem. 277 (2002) 2614-2619
17. Fujino H., Chen X.B., Regan J.W., and Murayama T. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells. Biochem. Biophys Res. Commun. 359 (2007) 568-573
18. 2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 278 (2003) 12151-12156
19. Kang H.J., Kim H.J., Rih J.K., Mattson T.L., Kim K.W., Cho C.H., Isaacs J.S., and Bae I. BRCA1 plays a role in the hypoxic response by regulating HIF-1α stability and by modulating vascular endothelial growth factor expression. J. Biol. Chem. 281 (2006) 13047-13056
20. 2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells. Vasc. Pharmacol. 44 (2006) 411-416
21. Fujino H., and Regan J.W. EP4 prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein. Mol. Pharmacol. 69 (2006) 5-10
22. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 9 (2006) 225-230
23. Marnett L.J., and DuBois R.N. COX-2: a target for colon cancer prevention. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 55-80
24. Fulton A.M., Ma X., and Kundu N. Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res. 66 (2006) 9794-9797